Biggest Blunders Pharma Marketers Make (And How To Correct Them)

PHANISH CHANDRA | October 25, 2017

article image
According to India Brand Equity Foundation, close to 80% of all medicines in India are prescription-based. This establishes doctors as the number one customer group of pharma marketers. Effective physician engagement, therefore, becomes the holy grail of pharma marketing success. However, the marketing approach that worked wonders in the past will prove to be blunderous in the coming years, the key reason being the rapidly changing world of medical practitioners.

Spotlight

Fort Dodge Animal Health

Fort Dodge Animal Health began in 1912 as a small serum manufacturer based in Fort Dodge, Iowa. Today, the company is headquartered in Overland Park, Kan., and has emerged as a leading global manufacturer of animal health products for the livestock, companion animal, equine, swine, and poultry industries. Fort Dodge is a committed partner to veterinary practitioners, livestock producers, and pet owners worldwide, and is dedicated to meeting their needs and making a difference in the future of animal health.

OTHER ARTICLES

Tips for Managing Chronic Pain Beyond Prescription Painkillers

Article | February 17, 2020

Painkillers like Oxycontin, Percocet, and Vicodin, have been prescribed by primary physicians, surgeons, dentists, and other healthcare providers to patients suffering from varying levels of pain. Though these medications have proven to be an effective source of pain relief, they have also proven to be highly addictive. In fact, it has even been reported that there are more cases of a drug overdose and deaths from prescription painkillers than heroin or cocaine. While there are a number of factors that play into this opioid epidemic, educating doctors and patients on alternative solutions to managing chronic pain is a great place to start combatting this nationwide crisis.

Read More

Clinical Supply Availability & Speed to Study Start-Up

Article | March 26, 2020

If you’re part of a clinical study team racing a new product to commercialization, you likely live by these two simple rules: time is money, and the first one to market wins. But just because it’s simple doesn’t mean it’s easy. That ticking clock is background noise to the responsibilities of regulations, study protocols, supply chains, and patient recruitment — all the details that must be worked out before a study can even begin. The pressure is always there. The longer it takes for a study to start, the longer it takes to complete.

Read More

As Pandemic Continues, Rafael Pharmaceuticals Enrolls Patients in Phase III Pancreatic Cancer Trial

Article | April 17, 2020

That simple truth about the severity of the disease is one of the reasons that Rafael Pharmaceuticals is slowly continuing with a Phase III trial in metastatic pancreatic cancer during the COVID-19 pandemic. While many companies have paused enrollment in clinical trials during the outbreak, Cranbury, N.J,-based Rafael opted to continue to enroll patients in its Phase III AVENGER 500 study of its lead compound CPI-613 (devimistat) in combination with modified Folfirinox (mFFX) as first-line therapy for the disease. Sanjeev Luther, president and chief executive officer of Rafael Pharmaceuticals, told BioSpace that the company made the decision to continue to enroll the trial, which was 75% filled, due to the short timeline patients with metastatic pancreatic cancer have. After discussing the matter of the trial with the company’s leadership team, Luther said they felt comfortable leaving the decision of whether or not the trial should continue to the conducting institute.

Read More

What to Watch in 2020: Non-Specialty Drugs

Article | March 1, 2020

Pharmaceutical manufacturers are constantly working to develop new and improved medications. Join us as we explore the non-specialty drugs you should be watching in 2020. If you missed last week’s article about the most important upcoming specialty drugs, be sure to check it out here. Approximately 40 new medications are approved by the Food and Drug Administration (FDA) every year.1 (Please note: If you’re curious about what it takes to develop a drug and bring it to market, check out our previous article). Why should you care about these new medications? Because they can affect both your organization’s pharmacy spend and your members’ cost share. For non-specialty drugs, we will focus on medications that may come to market this year, including ones that are currently being reviewed by the FDA, or that are in the last clinical trial (Phase III) stage.

Read More

Spotlight

Fort Dodge Animal Health

Fort Dodge Animal Health began in 1912 as a small serum manufacturer based in Fort Dodge, Iowa. Today, the company is headquartered in Overland Park, Kan., and has emerged as a leading global manufacturer of animal health products for the livestock, companion animal, equine, swine, and poultry industries. Fort Dodge is a committed partner to veterinary practitioners, livestock producers, and pet owners worldwide, and is dedicated to meeting their needs and making a difference in the future of animal health.

Events